Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. File:Novartis-Logo.svg - Wikipedia

   en.wikipedia.org/wiki/File:Novartis-Logo.svg

   File:Novartis-Logo.svg. Size of this PNG preview of this SVG file: 512 × 84 pixels. Other resolutions: 320 × 53 pixels | 640 × 105 pixels | 1,024 × 168 pixels | 1,280 × 210 pixels | 2,560 × 420 pixels. Original file ‎ (SVG file, nominally 512 × 84 pixels, file size: 2 KB) This is a file from the Wikimedia Commons.

3. Novartis - Wikipedia

   en.wikipedia.org/wiki/Novartis

   Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

4. Sacubitril/valsartan - Wikipedia

   en.wikipedia.org/wiki/Sacubitril/valsartan

   During its development by Novartis, Entresto was known as LCZ696. It was approved under the FDA's priority review process on 7 July 2015. It was also approved in Europe in 2015. In 2022, Novartis sold its India marketing rights of Sacubitril Valsartan to JB Pharma, under the brand name Azmarda. Society and culture Trial design

5. Linux - Wikipedia

   en.wikipedia.org/wiki/Linux

   It starts processes such as system services and login prompts (whether graphical or in terminal mode). Software libraries, which contain code that can be used by running processes. On Linux systems using ELF-format executable files, the dynamic linker that manages the use of dynamic libraries is known as ld-linux.so.

6. California fines Amazon $6M for alleged violations of ...

   www.aol.com/finance/california-fines-amazon-6m...

   The California Labor Commissioner's Office has fined Amazon a total of $5.9 million following accusations the company violated the state's Warehouse Quota Law.

7. Novartis begins tender offer for cancer-focused MorphoSys - AOL

   www.aol.com/news/novartis-begins-tender-offer...

   BERLIN (Reuters) -Novartis said on Thursday it has launched a tender offer to acquire MorphoSys, a German developer of cancer treatments, for an aggregate 2.7 billion euros ($2.9 billion).